Broxmeyer Hal E, Dent Alexander, Cooper Scott, Hangoc Giao, Wang Zheng-Yu, Du Wenjun, Gervay-Haque Jacquelyn, Sriram Venkataraman, Renukaradhya Gourapura J, Brutkiewicz Randy R
Department of Microbiology and Immunology and the Walther Oncology Center, Indiana University School of Medicine, and the Walther Cancer Institute, Indianapolis, IN 46202, USA.
Exp Hematol. 2007 Apr;35(4 Suppl 1):87-93. doi: 10.1016/j.exphem.2007.01.015.
Infection of immunocompromised patients with cytomegalovirus (CMV), such as that occurring in patients undergoing hematopoietic stem cell transplantation, is a serious clinical problem. CMV infection has been reported to suppress hematopoiesis. In immunocompetent hosts CMV is controlled initially by the innate immune system, with CD1d molecules and natural killer T (NKT) cells playing a role in the antiviral immune response in several model systems. We hypothesized that CD1d and NKT cells are involved in protection of the hematopoietic modulating effects of CMV, and that adoptive transfer of NKT cells would protect against these infection-induced effects.
To address our hypothesis, we used a murine CMV (MCMV) infection model in CD1d(-/-), Jalpha18(-/-), and wild-type (WT) control mice of two different genetic strains each.
Infection with MCMV was associated with significant suppression of absolute numbers and cell cycling status of myeloid progenitor cells (CFU-GM, BFU-E, CFU-GEMM) in the marrow and spleen, especially in CD1d(-/-) (lack both CD1d and NKT cells), and Jalpha18(-/-) (express CD1d but lack NKT cells) mice. Adoptive transfer of NKT cells into WT and Jalpha18(-/-) mice shortly before infection with MCMV counteracted myelosuppression.
The results implicate NKT cells, and also likely CD1d, in protection of progenitor cells from MCMV-induced suppression and suggest that NKT cells may be of value in an adoptive transfer setting to treat CMV-induced perturbations of hematopoiesis in immunocompromised individuals. However, further studies are required to better understand the full consequences of adoptive transfer in these settings.
免疫功能低下患者感染巨细胞病毒(CMV),如造血干细胞移植患者发生的感染,是一个严重的临床问题。据报道,CMV感染会抑制造血功能。在免疫功能正常的宿主中,CMV最初由先天免疫系统控制,在多个模型系统中,CD1d分子和自然杀伤T(NKT)细胞在抗病毒免疫反应中发挥作用。我们假设CD1d和NKT细胞参与保护造血免受CMV的调节作用,并且NKT细胞的过继转移将预防这些感染诱导的效应。
为了验证我们的假设,我们在两种不同遗传品系的CD1d基因敲除(-/-)、Jalpha18基因敲除(-/-)和野生型(WT)对照小鼠中使用了鼠巨细胞病毒(MCMV)感染模型。
感染MCMV与骨髓和脾脏中髓系祖细胞(CFU-GM、BFU-E、CFU-GEMM)的绝对数量和细胞周期状态的显著抑制有关,特别是在CD1d基因敲除(-/-)(缺乏CD1d和NKT细胞)和Jalpha18基因敲除(-/-)(表达CD1d但缺乏NKT细胞)小鼠中。在感染MCMV前不久将NKT细胞过继转移到WT和Jalpha18基因敲除(-/-)小鼠中可抵消骨髓抑制。
结果表明NKT细胞以及可能还有CD1d参与保护祖细胞免受MCMV诱导的抑制,并表明NKT细胞在过继转移环境中可能对治疗免疫功能低下个体中CMV诱导的造血紊乱有价值。然而,需要进一步研究以更好地了解这些环境中过继转移的全部后果。